Assurance Infusion is recalling 2,535 units of various compounded medications, including Alprostadil, Autologous Serum eye drops, and numerous pain management injections like Morphine, Fentanyl, and Hydromorphone. These products are being recalled because the company cannot guarantee they are sterile. The recall affects a wide range of injectable solutions in vials and syringes distributed nationwide between 2019 and early 2020. Consumers should immediately stop using any affected medication and contact their healthcare provider to discuss alternative treatments.
Using a drug intended to be sterile that is not sterile can lead to life-threatening infections at the site of injection or in the blood. While no specific injuries were reported in this notice, the lack of sterility assurance poses a significant health risk to patients receiving these medications.
Refund for unused product.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.